发明公开
EP2178557A1 COMPOSITION OF TUMOUR-ASSOCIATED PEPTIDES AND RELATED ANTI-CANCER VACCINE
有权
ZUSAMMENSETZUNG VON TUMORASSOZIIERTEN PEPTIDEN UND VERWANDTER IMPFSTOFF GEGEN KREBS
- 专利标题： COMPOSITION OF TUMOUR-ASSOCIATED PEPTIDES AND RELATED ANTI-CANCER VACCINE
- 专利标题（中）： ZUSAMMENSETZUNG VON TUMORASSOZIIERTEN PEPTIDEN UND VERWANDTER IMPFSTOFF GEGEN KREBS
-
申请号： EP08785105.1申请日： 2008-07-25
-
公开(公告)号： EP2178557A1公开(公告)日： 2010-04-28
- 发明人: SINGH, Harpreet , SCHOOR, Oliver , TRAUTWEIN, Claudia , HILF, Norbert , WEINSCHENK, Toni , WALTER, Steffen , LEWANDROWSKI, Peter
- 申请人： Immatics Biotechnologies GmbH
- 申请人地址： Paul-Ehrlich-Strasse 15 72076 Tübingen DE
- 专利权人： Immatics Biotechnologies GmbH
- 当前专利权人： Immatics Biotechnologies GmbH
- 当前专利权人地址： Paul-Ehrlich-Strasse 15 72076 Tübingen DE
- 代理机构： Krauss, Jan
- 优先权： EP07014796 20070727; US953109P 20070731; US981241P 20071019
- 国际公布： WO2009015841 20090205
- 主分类号： A61K39/00
- IPC分类号： A61K39/00 ; A61P35/00 ; A61K38/08 ; A61K38/16
摘要：
The present invention relates to immunotherapeutic peptides and their use in immunotherapy, in particular the immunotherapy of cancer. The present invention discloses tumour-associated T-helper cell peptide epitopes, alone or in combination with other tumour-associated peptides that serve as active pharmaceutical ingredients of vaccine compositions which stimulate anti-tumour immune responses. In particular, the composition of the peptides of the present invention can be used in vaccine compositions for eliciting anti-tumour immune responses against colorectal cancer.
公开/授权文献
信息查询
